Predictor of adverse pathology in patients who underwent deferred radical prostatectomy following active surveillance: Results from multi-institutional prospective observational cohort in the PRIAS-JAPAN.

Authors

null

Yoichiro Tohi

Kagawa University, Kagawa, Japan

Yoichiro Tohi , Ryou Ishikawa , Takuma Kato , Jimpei Miyakawa , Ryuji Matsumoto , Keiichiro Mori , Koji Mitsuzuka , Junichi Inokuchi , Masafumi Matsumura , Kenichiro Shiga , Hirohito Naito , Yasuo Kohjimoto , Norihiko Kawamura , Masaharu Inoue , Shusuke Akamatsu , Naoki Terada , Yoshiyuki Miyazawa , Shintaro Narita , Reiji Haba , Mikio Sugimoto

Organizations

Kagawa University, Kagawa, Japan, Kagawa University Graduate School of Medicine, Kagawa, Japan, The University of Tokyo, Tokyo, Japan, Hokkaido University, Hokkaido, Japan, Jikei University School of Medicine, Tokyo, Japan, Tohoku University, Sendai, Japan, Kyushu University, Fukuoka, Japan, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan, Harasanshin Hospital, Fukuoka, Japan, Kurashiki Central Hospital, Kurashiki, Japan, Wakayama Medical University, Wakayama, Japan, Department of Urology, Osaka International Cancer Institute, Osaka, Japan, Saitama Cancer Center, Saitama, Japan, The Department of Urology, Kyoto University, Kyoto-Shi, Japan, University of Miyazaki, Miyazaki, Japan, Gunma University Hospital, Maebashi-Shi, Japan, Akita University, Akita, Japan, Kagawa University Hospital, Kagawa, Japan

Research Funding

No funding received
None.

Background: Intraductal carcinoma of the prostate (IDC-P) and invasive cribriform are key prognostic pathologies among early stage prostate cancer patients; however, predictors of adverse pathology, including these types, remain unknown. In men who opted for active surveillance (AS), we aimed to examine the association between adverse pathology and patient characteristics, utilizing radical prostatectomy (RP) specimens. Methods: We re-reviewed available RP specimens from 1035 men prospectively enrolled in the PRIAS-JAPAN cohort between January 2010 and September 2020. We defined adverse pathology on RP specimen as Gleason grade group of ≥3, pT-stage≥T3, pN positivity, or the presence of IDC-P or invasive cribriform. And, we examined the predictive factors associated with adverse pathology, using factors at AS enrollment and before RP. Results: Out of 162 men underwent RP, available 137 RP specimens were analyzed. The percentage of adverse pathology was 48.9% (67 patients), including 8.8% in IDC-P and 29.9 % in invasive cribriform. Men with adverse pathology had lower prostate specific antigen recurrence-free survival than those without them (log rank P = 0.0189). On multivariate logistic regression analyses, increasing age at AS enrollment and before RP were the predictive factors for adverse pathology (Odds ratio [OR], 1.1; 95% confidence interval [CI]: 1.02-1.19, P = 0.0178, OR, 1.12; 95% CI: 1.02-1.22, P=0.0126), not magnetic resonance imaging findings. Conclusions: Aging is significantly associated with adverse pathology including IDC-P or cribriform. The results suggest that relaxing scheduled examinations during AS depending on age is not practical. Clinical trial information: UMIN000048095.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2023 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer - Advanced,Prostate Cancer - Localized

Sub Track

Therapeutics

Clinical Trial Registration Number

UMIN000048095

Citation

J Clin Oncol 41, 2023 (suppl 6; abstr 350)

DOI

10.1200/JCO.2023.41.6_suppl.350

Abstract #

350

Poster Bd #

M8

Abstract Disclosures

Similar Abstracts

First Author: Eric Li

Abstract

2019 Genitourinary Cancers Symposium

A 17-gene genomic prostate score as a predictor of adverse pathology for men on active surveillance.

First Author: Zachary Kornberg

Abstract

2021 Genitourinary Cancers Symposium

Adverse pathology as a predictor of distant metastasis and prostate cancer mortality with 20-year follow up.

First Author: Michael Austin Brooks